Northwest Biotherapeutics (NWBO) Asset Utilization Ratio (2011 - 2026)

Northwest Biotherapeutics' Asset Utilization Ratio history runs 16 years deep, the most recent figure standing at 0.02 for Q1 2026.

• In Q1 2026, Asset Utilization Ratio fell 65.84% year-over-year to 0.02; the TTM figure through Mar 2026 stood at 0.02 (down 65.84% YoY), while the FY2025 annual figure was 0.03, down 49.61% from the prior year.
• Asset Utilization Ratio for Q1 2026 stood at 0.02, down from 0.02 in the prior quarter.
• The five-year high for Asset Utilization Ratio was 0.07 in Q3 2023, with the low at 0.02 in Q1 2026.
• The 5-year median for Asset Utilization Ratio is 0.05 (2024), against an average of 0.05.
• The sharpest annual moves came in 2023 and 2026: Asset Utilization Ratio soared 103.84% in 2023, then tumbled 65.84% in 2026.
• Northwest Biotherapeutics' Asset Utilization Ratio stood at 0.05 in 2022, then climbed by 20.72% to 0.07 in 2023, then retreated by 24.25% to 0.05 in 2024, then sank by 50.06% to 0.02 in 2025, then dropped by 24.66% to 0.02 in 2026.
• Business Quant data shows NWBO's Asset Utilization Ratio at 0.02 in Q1 2026, 0.02 in Q4 2025, and 0.03 in Q3 2025.